FABBS reports on items of interest to many communities – scientists, policymakers, and the public. In our news, you will see updates on science funding and policy, articles that translate research for policy, and descriptions of the research contributions of scientists at all stages of their research careers.
FY 2018 Federal Funding Set, but Work Continues on NIH Clinical Trials
March 28, 2018
The omnibus bill to fund the federal government in FY 2018 was signed into law on Friday, March 23, 2018. The two-year budget deal reached on February 9, 2018, increased spending caps for both defense and nondefense in the budget, making it easier to get the FY 2018 bills over the finish line. Still, it wasn’t easy, and took almost six months into the fiscal year to complete.
The $1.3 trillion omnibus, over 2200 pages in length, included all twelve annual spending
read moreChallenges Remain for NSF Social, Behavioral, and Economic Sciences in FY 2019
March 28, 2018
The House Committee on Space, Science and Technology (SST) held a hearing on March 16, 2018, to review the Administration’s 2019 fiscal year budget proposal for the National Science Foundation (NSF). Witnesses present at the hearing included Dr. France Cordova, Director of the NSF; Dr. Maria T. Zuber, Chair of the National Science Board (NSB); and Dr. Joan Ferrini-Mundy, CEO of the NSF.
Chairman Lamar Smith (R-TX) and other Republican members of the committee stated
read moreBudget Deals, Side Deals, and An Addendum: The Confusing State of Federal Science Funding
February 20, 2018
As Congressional leaders geared up to pass a fifth Continuing Resolution to keep the federal government funded in a fiscal year that began almost 6 months ago, there was increased enthusiasm that a budget deal to lift the sequestration level spending caps was possible. A deal was finally reached, and science advocates celebrated. Raising the caps meant more wiggle room in the federal budget to fund science agencies and now appropriators could begin the process of completing
read moreIndividualized Medicine with No Side Effects? It’s Already Here
February 16, 2018
We live in an age of personalization, and medicine is increasingly part of that trend. Recent advances in genetic research have allowed medications to be tailored to a person’s DNA profile, for example. But another form of ‘individualized medicine’ has been around far longer: biofeedback, a therapeutic intervention in which patients are trained to recognize and modify their biorhythms. Using electronic monitoring, biofeedback practitioners help patients become aware
read more